Skip to main content

NASDAQ:SOLY - Soliton Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $20.33
  • Forecasted Upside: 12.96 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$18.00
▲ +0.62 (3.57%)
1 month | 3 months | 12 months
Get New Soliton Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SOLY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SOLY

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$20.33
▲ +12.96% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Soliton in the last 3 months. The average price target is $20.33, with a high forecast of $25.00 and a low forecast of $16.00. The average price target represents a 12.96% upside from the last price of $18.00.

Buy

The current consensus among 2 contributing investment analysts is to buy stock in Soliton.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/14/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/12/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/12/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/10/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/8/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/6/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/7/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/7/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/5/2021Maxim GroupReiterated RatingBuy$25.00High
i
2/8/2021Maxim GroupBoost Price TargetBuy$22.00 ➝ $25.00Medium
i
2/2/2021Cantor FitzgeraldBoost Price TargetOverweight$12.00 ➝ $20.00Low
i
7/15/2020Cantor FitzgeraldInitiated CoverageOverweight$12.00High
i
Rating by L. Chen at Cantor Fitzgerald
7/2/2020Maxim GroupReiterated RatingBuy$22.00Low
i
Rating by Anthony Vendetti at Maxim Group
6/16/2020Roth CapitalBoost Price Target$14.00 ➝ $16.00High
i
Rating by S. Henry at Roth Capital
4/3/2020Maxim GroupReiterated RatingBuy$22.00High
i
Rating by Anthony Vendetti at Maxim Group
3/27/2020Roth CapitalInitiated CoverageBuy$14.00Low
i
Rating by S. Henry at Roth Capital
3/4/2020Maxim GroupReiterated RatingBuy$22.00Low
i
Rating by Anthony Vendetti at Maxim Group
12/5/2019Maxim GroupInitiated CoverageBuy$22.00Medium
i
(Data available from 5/8/2016 forward)
Soliton logo
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas.
Read More

Today's Range

Now: $18.00
$17.18
$18.31

50 Day Range

MA: $17.20
$14.67
$18.85

52 Week Range

Now: $18.00
$5.69
$19.65

Volume

123,837 shs

Average Volume

320,725 shs

Market Capitalization

$381.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.24

Frequently Asked Questions

What sell-side analysts currently cover shares of Soliton?

The following equities research analysts have issued research reports on Soliton in the last year: Cantor Fitzgerald, Maxim Group, Roth Capital, and Zacks Investment Research.
View the latest analyst ratings for SOLY.

What is the current price target for Soliton?

3 Wall Street analysts have set twelve-month price targets for Soliton in the last year. Their average twelve-month price target is $20.33, suggesting a possible upside of 12.8%. Maxim Group has the highest price target set, predicting SOLY will reach $25.00 in the next twelve months. Roth Capital has the lowest price target set, forecasting a price of $16.00 for Soliton in the next year.
View the latest price targets for SOLY.

What is the current consensus analyst rating for Soliton?

Soliton currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SOLY will outperform the market and that investors should add to their positions of Soliton.
View the latest ratings for SOLY.

What other companies compete with Soliton?

How do I contact Soliton's investor relations team?

Soliton's physical mailing address is 5304 ASHBROOK DRIVE, HOUSTON TX, 77081. The company's listed phone number is 844-705-4866. The official website for Soliton is www.soliton.com.